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Objectives. We report the clinical course and unique hemody-
namic findings after placement of a supraannular mitral valve
prosthesis.
Background. Children with symptomatic mitral valve disease
whose annulus is too small for the smallest prosthesis are difficult
to manage. One option is valve replacement with a prosthesis
positioned entirely within the left atrium (LA).
Methods. We reviewed 17 patients (median age 10 months) with
symptomatic mitral valve disease who underwent placement of a
supraannular valve prosthesis between 1980 and 1994.
Results. The actuarial survival rates were 88% at 1 month and
71%, 62% and 53% at 1, 2 and 10 years, respectively. Preoperative
hemodynamic data (mean 6 SD) compared with those after
placement of the supraannular mitral prosthesis were as follows:
“a” wave to left ventricular end-diastolic pressure gradient 17 6
5 versus 4 6 4 mm Hg (p 5 0.003), mean LA pressure 25 6 6
versus 20 6 6 mm Hg (p 5 0.07), “a” wave 30 6 6 versus 19 6
5 mm Hg (p 5 0.006), “v” wave 28 6 5 versus 30 6 9 mm Hg (p 5
0.31), mean pulmonary artery pressure 54 6 19 versus 42 6
15 mm Hg (p 5 0.07) and left ventricular end-diastolic pressure
14 6 5 versus 16 6 4 mm Hg (p 5 0.12).
Conclusions. Supraannular mitral valve replacement provides
relief of mitral stenosis or mitral regurgitation. However, LA to
left ventricular early diastolic gradients with large atrial “v”
waves contribute to elevated mean LA pressures in the absence of
prosthetic valve obstruction or regurgitation. As a result of this
unexpected finding, associated left heart obstructive lesions and
pulmonary and left ventricular end-diastolic hypertension, the
outlook remains poor.
(J Am Coll Cardiol 1997;29:1089–94)
©1997 by the American College of Cardiology
Congenital mitral valve disease is uncommon and severe
congenital mitral stenosis (MS) requiring valve replacement in
infancy is even rarer (1). Nevertheless, valve replacement may
be the only option for small children with congenital MS,
particularly if balloon dilation has failed or resulted in intol-
erable regurgitation (1). Therefore, children requiring mitral
valve replacement whose native annulus is too small to accept
the smallest prosthesis available present a difficult manage-
ment problem. One approach, which is feasible in only a subset
of patients, is surgical repair of the mitral valve (2). An
alternative option is replacement of the mitral valve with a
prosthesis positioned above the native annulus entirely within
the left atrium (LA). As the operative mortality after supra-
annular mitral valve replacement (SMVR) has improved (3,4),
these children have required late hemodynamic prosthesis
assessment to aid future management. The purposes of this
study are to review our experience with SMVR with the
emphasis on subsequent hemodynamic observations and to
attempt an explanation of these findings and their use as
indicators for further intervention. Furthermore, this analysis
may be helpful when deciding between the treatment options
of a Norwood-type single-ventricle palliation or heart trans-
plantation versus a two-ventricle repair for neonates who have
multiple left heart obstructive lesions.
Methods
Patients. Between 1980 and 1994, 17 patients (10 females)
underwent mitral valve replacement with a prosthesis in the
supra-annular position. They ranged in age from 3 months to
3.5 years (median 10 months) at the time of this procedure. All
available data, including echocardiographic, cardiac catheter-
ization and surgical information, were reviewed in detail and
form the basis of this report. The data were analyzed and
presented as follows: 1) preoperative evaluation (i.e., before
SMVR) of associated lesions, procedures and mitral valve
echocardiographic features (Table 1); 2) indications for and
observations at the time of SMVR (Table 2); 3) comparison of
cardiac catheterization data before and after SMVR; and 4)
clinical course after SMVR (Table 2).
Statistical analysis. Preoperative hemodynamic data were
compared with postoperative data using the paired Student t
test. A p value ,0.05 was considered significant. Actuarial
survival was calculated using the Kaplan-Meier method.
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Results
Associated lesions and previous procedures (Table 1). In
addition to the mitral valve lesion, all but one patient (no. 7)
had associated congenital heart disease. Previous surgical
repair of aortic coarctations had been performed in eight
patients, resection of supramitral stenosing rings in three and
repair of ventricular septal defects in four (two of these had
atrioventricular canal defects). Stenotic mitral valves were
balloon dilated in nine patients, with resultant regurgitation,
and a patent ductus arteriosus was closed with a coil in one
patient. Thus, 10 of 17 patients had had a previous unsuccess-
ful attempt to relieve MS.
Supraannular mitral valve replacement (Table 2). The
indications for SMVR were MS in nine patients (due to prior
prosthesis stenosis in one of these, Patient 7), both MS and
mitral regurgitation (MR) in six and pure MR in two. Mitral
valve apparatus abnormalities were evident in all 17 with
available echocardiographic data. The mitral annulus mean
(6SD) diameter was 12 6 2.5 mm (with a median Z score
20.8; range 23.8 to 1.9), requiring placement of the prosthesis
in the supra-annular position.
Preoperative hemodynamic data. At cardiac catheteriza-
tion the mean (6SD) LA “a” wave was 30 6 6 mm Hg, LA “v”
wave 28 6 5 mm Hg, LA mean pressure 25 6 6 mm Hg, left
Table 1. Data Before Supraannular Mitral Valve Replacement
Pt
No. Gender Associated Lesions
Previous Procedures With
Age (mo) Echocardiographic Features
1 F PDA, VSD PDA coil occlusion (2) MV
dilation (2)
Peak D20 mean D8, annulus
12 mm, Z score 1.1
2 M AV canal, HOCM,
subAS
AV canal repair with
relocation of chordae
and myomectomy (2)
Annulus 13 mm, Z score 1.2
3 M BAV, ASD, VSD,
PDA, subAS
ASD, VSD closure (2) Annulus 8 mm, Z score 3.3
4 F BAV, subAS, mild CoA MV dilation (7) Peak D33 mean D22, annulus
7 mm, Z score 3.8
5 F CoA, AS, subAS, VSD,
double Ao arch
CoA repair, PA band (0.1),
PA repair, resection
supraMS, VSD closure
(5), MV dilation (8)
Annulus 13 mm, Z score 0.3
6 F CoA, BAV CoA repair (0.3) Annulus 15 mm, Z score 1.3
7 M MV endocarditis 17 B-S in annulus (3.6) NA
8 F CoA CoA repair (7) NA
9 M VSD Resection supraMS (8),
MV plasty, VSD closure,
MV dilation (18)
Peak D18 mean D10, annulus
9 mm, Z score 2.8
10 M CoA, BAV, AS CoA repair (6), MV
dilation (19)
Peak D19 mean D10, annulus
13 mm, Z score 0.8
11 M BAV, AS, subAS, VSD,
CoA
CoA repair (0.3) Peak D18 mean D7, annulus
12 mm, Z score 1.3
12 F CoA CoA repair (0.4), MV
dilation (28), MV
dilation (41)
Peak D28 mean D20, annulus
12 mm, Z score 1.7
13 M CoA, BAV CoA repair (0.5), MV
dilation (18)
Annulus 15 mm, Z score 1.9
14 F VSD MV dilation (16) Peak D26 mean D18, annulus
13 mm, Z score 0.3
15 F VSDs MV dilation (6), MV
dilation (8)
Peak D22 mean D15, annulus
14 mm, Z score 0.5
16 F AV canal Repair (6) Annulus 14 mm, Z score 0.9
17 F CoA, VSDs CoA repair (1), resection
supraMS (18)
Peak D20 mean D14, annulus
12 mm, Z score 1.0
Ao 5 aortic; AS 5 aortic stenosis; ASD 5 atrial septal defect; AV 5 atrioventricular; BAV 5 bicuspid aortic valve;
B-S 5 Bjork-Shiley; CoA 5 aortic coarctation; F 5 female; HOCM 5 hypertrophic obstructive cardiomyopathy; M 5
male; MV 5 mitral valve; NA 5 not available; PA 5 pulmonary artery; PDA 5 patent ductus arteriosus; supraMS 5
supra mitral stenosing ring; VSD 5 ventricular septal defect; D 5 gradient.
Abbreviations and Acronyms
LA 5 left atrium, left atrial
LVED 5 left ventricular end-diastolic
MR 5 mitral regurgitation
MS 5 mitral stenosis
PA 5 pulmonary artery
SMVR 5 supraannular mitral valve replacement
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ventricular end-diastolic (LVED) pressure 14 6 5 mm Hg and
LA “a” wave to LVED pressure gradient 17 6 5 mm Hg. All
patients had pulmonary hypertension with a mean pulmonary
artery (PA) pressure 54 6 19 mm Hg. In three patients, severe
MR was the primary lesion and indication for mitral valve
replacement. Mitral regurgitation followed repair of a com-
plete atrioventricular canal in two patients (Patients 2 and 16)
(complicated by hypertrophic cardiomyopathy and left ventric-
ular outflow tract obstruction in one patient [Patient 2]). One
child (Patient 7) without congenital heart disease developed
severe MR after acute bacterial endocarditis. This child ini-
tially underwent mitral valve replacement with a no. 17 Bjo¨rk-
Shiley prosthesis placed in the annular position, but 1 year
later, because of prosthetic valve stenosis, underwent SMVR
with a no. 21 St. Jude prosthesis.
Mitral valve replacement was performed using the largest
prosthesis available that could be placed in the supra-annular
position. The following prostheses were used: no. 17 Bjo¨rk-
Shiley (n 5 6), no. 19 St. Jude (n 5 4), no. 21 St. Jude (n 5 1)
and no. 16 Carbomedics (n 5 6). All patients received long-
term anticoagulation postoperatively.
Hemodynamic data after SMVR. Of the 17 patients, post-
operative hemodynamic data were available in 12. Nine pa-
tients have undergone postoperative cardiac catheterization,
three patients have been catheterized on three occasions and
two twice. In seven patients, direct LA with simultaneous
LVED pressure was used and in two PA wedge and simulta-
neous LVED pressure was used. In three patients, not yet
catheterized after SMVR, postoperative traces of LA, PA and
systemic arterial pressures, obtained on the intensive care unit,
were available for analysis.
Postoperatively there was a reduction of the mean (6SD)
LA “a” wave to LVED pressure gradient from 17 6 5 to 4.5 6
4 mm Hg (p 5 0.006), with a significant fall in the LA “a” wave
from 30 6 6 to 19 6 5 (p 5 0.003). However, there was no
significant change in LA “v” wave (30 6 9 mm Hg, p 5 0.31),
mean LA pressure (20 6 6 mm Hg, p 5 0.07), LVED pressure
(16 6 4 mm Hg, p 5 0.12) or mean PA pressure (42 6
15 mm Hg, p 5 0.07).
Characteristically all patients had very tall “v” waves, which
occurred in the absence of LA “a” wave to LVED pressure
gradients or MR (neither angiographic nor echocardiographic)
(Fig. 1). The peak of the “v” wave occurred close to the
downstroke of ventricular diastole and the rate of fall or Ry/v
of 1.12 6 0.15 (6SD) was not typical of either the Ry/v ratio of
MS (range 0.6 to 1.0) or MR (range 2.0 to 6.0) (5). There were
two exceptions to the finding of large “v” waves (the only two
patients without direct LA pressure measurements), and in
these two patients the “v” waves were only between 2 and
4 mm Hg greater than the mean PA wedge pressure. Both of
these patients died after SMVR. In one, pulmonary vein
obstruction by the prosthesis was evident on autopsy. In all but
one patient, pulmonary hypertension persisted, again in the
absence of MR or MS. The exception (Patient 7) underwent
valve replacement for isolated MR due to bacterial endocar-
ditis in an otherwise normal heart.
Postoperative angiography. Angiography of the left ventri-
cle produced a characteristic picture (Fig. 2). The prosthesis
Table 2. Details at Time of Supraannular Mitral Valve Replacement and Clinical Course After the Procedure
Pt
No. Reason for Operation
Age
(mo)
Weight
(kg) Procedure Alive/Dead
Interval Since
SMVR (yr)
Echocardiography
Peak
Gradient*
Mean
Gradient*
Pressure
Half-Time*
1 MS, MR 3 3.9 19-mm St. Jude Alive 1.8 5.5 2.6 31
2 MR, subAS 3 3.8 17-mm Bjork-Shiley Alive 3.9 10.3 5 55
3 MS 5 5.6 16-mm Carbomedics Dead 2 15.3 5.4 42
4 MS, MR, subAS 8 5.6 17-mm Bjork-Shiley,
resection of subAS
Dead 0.1 9.2 4.9 59
5 MS 9 5.6 17-mm Bjork-Shiley Dead 2.5 15.4 8 57
6 MS 10 5.5 17-mm Bjork-Shiley Alive 7.7 21.9 9.5 82
7 Annular prosthetic MS 10 7.7 21-mm St. Jude Alive 14.1 25.1 9.4 146
8 MS 11 6.4 17-mm Bjork-Shiley Alive 14.1 NA NA NA
9 MS, MR 19 7.1 17-mm Bjork-Shiley Alive 4.2 18.8 4.4 90
10 MS, MR 19 8.5 16-mm Carbomedics Alive 3.5 11.7 4 40
11 MS 23 9 19-mm St. Jude,
VSD closure
Dead 0.3 NA NA NA
12 MR, MS 45 9.6 19-mm St. Jude Alive 1.6 22.5 5.1 73
13 MS 19 9.3 16-mm Carbomedics Dead 0 NA NA NA
14 MS, MR 18 8.2 16-mm Carbomedics Dead 0 10.4 3.3 19
15 MS 9 6.6 16-mm Carbomedics Alive 1.1 12.1 4 25
16 MR 6 4 19-mm St. Jude Dead 0.5 Medial leaflet open and immobile
17 MS 31 7.9 16-mm Carbomedics Alive 0.5 8 2 74
*Measured in millimeters of mercury (mm Hg). AS 5 aortic stenosis; MR 5 mitral regurgitation; MS 5 mitral stenosis; NA 5 not available; SMVR 5 supraannular
mitral valve replacement; VSD 5 ventricular septal defect.
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was very mobile. During diastole the valve moved toward the
LA. At the beginning of ventricular systole, just before
the opening of the aortic valve, the “ventricularized” portion of
the atrium beneath the valve expanded, and the prosthesis
moved transiently and abruptly further backward to compress
the remnant of the LA. With continued ventricular contraction
the prosthesis moved farther away from the apex.
No child had significant MR by either angiographic assess-
ment or echocardiography. All valve leaflets appeared to be
functioning well by fluoroscopy in those who underwent car-
diac catheterization.
Echocardiography after SMVR. The echocardiographic
features mirrored in many respects the angiographic findings.
The prosthesis appeared mobile and moved paradoxically away
from the ventricular apex during systole.
Analysis of the diastolic Doppler wave form in 13 patients
who did not have regurgitation or stenosis of the prosthesis
yielded a peak early diastolic gradient of 14.0 6 6.1 mm Hg, a
mean gradient of 5.2 6 2.4 mm Hg and a pressure half-time of
61 6 34.0 ms, all values are mean 6 SD. The prosthetic valve
flow typically demonstrated an early diastolic peak gradient
that decreased rapidly and was absent at end-diastole. A
Doppler “a” wave was usually not discernible (Fig. 3). In one
patient who was not catheterized malfunction of the anterior
prosthetic leaflet, which failed to close in ventricular systole,
was seen. In another patient, a vegetation on the prosthesis was
noted and confirmed during surgical replacement.
Clinical course. Actuarial survival rates were 88% at 30
days, 71% at 1 year, 62% at 2 years and 53% at 5 and 10 years.
There have been seven deaths, and five patients have required
reoperation. Two children died in the immediate postoperative
period with pulmonary hypertension and low cardiac output.
Autopsy in Patient 13 demonstrated obstruction of the left
pulmonary veins by the prosthesis and a small hypertrophied
LA proximal to the prosthesis with endocardial fibroelastosis,
also present in the left ventricle.
Five children died late at 2 months, 4 months, 6 months, 2
years and 2.5 years after the operation. Postmortem examina-
tions were carried out in three children. In Patient 4 the mitral
prosthesis was judged to be obstructing the lower pulmonary
veins, and in both Patients 4 and 5 the supraannular prosthesis
was clean and functioning well. Autopsy findings common to
both patients included a small hypertrophied LA proximal to
the prosthesis with dilation of the appendage and marked
endocardial fibrosis diffusely involving the left ventricle and
atrium. The pulmonary vasculature demonstrated histologic
changes of severe pulmonary vascular disease. Patients 3
(confirmed at autopsy) and 16 died after acute obstruction of
the mitral prosthesis.
Four children were reoperated on because of concern about
Figure 1. Representative simultaneous LA and left ventricular pres-
sure tracing before (Pre Op MS) and after (Post MVR in LA)
supraannular mitral valve replacement. Note persistence of the “v”
wave postoperatively but virtual abolition of the “a” wave to left
ventricular gradient.
Figure 2. Levophase of a pulmonary artery angiogram after supra-
annular mitral valve replacement. The small left atrium, unobstructed
pulmonary venous return, the small native annulus and the “ventricu-
larized” atrium are all demonstrated.
Figure 3. Representative continuous wave Doppler tracing after su-
praannular mitral valve replacement. Note the high early diastolic
gradient, which falls rapidly and is obliterated at end-diastole, similar
to hemodynamic tracings obtained at cardiac catheterization.
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the prosthesis. In two patients the prosthesis was functioning
normally despite high LA pressures and tall “v” waves. How-
ever, in Patients 8 and 2, who had an “a” wave to LVED
gradient, there was pannus ingrowth obstructing the prosthesis.
Both patients underwent successful prosthesis replacement,
one in the annular position.
Discussion
General findings. The management of children with vari-
able degrees of symptomatic left heart inflow and outflow
obstruction who do not fit the criteria for single-ventricle
palliation in the neonatal period remains extremely challeng-
ing. We report replacement of the mitral valve with a prosthe-
sis entirely within the LA in infants as young as 3 months and
weighing as little as 3.8 kg. The early surgical mortality rate was
12%. However, alleviation of the mitral valve gradient alone
was not sufficient to return LA pressure to normal, probably
because of a persistent elevation in LVED pressure and the
hemodynamic findings suggestive of a noncompliant LA.
Follow-up cardiac catheterization of these complex patients
documented an interesting hemodynamic profile. Despite a
well-functioning prosthesis, we observed the triad of elevated
LA “v” waves and left ventricular end-diastolic and pulmonary
artery hypertension. The outcome of the children who under-
went reoperation suggests that an early diastolic gradient and
pulmonary hypertension do not imply prosthesis stenosis in the
absence of abnormal valve movement. Failure to appreciate
the significance of the elevated LA “v” wave and thus mean LA
pressure resulted in an unnecessary surgical procedure in two
of our patients.
Left atrial hemodynamic data. The hemodynamic profile
in this cohort of children might be related to a combination of
factors. The presence of a rigid prosthetic ring in a normally
compliant part of an already small and hypertrophied LA
whose volume has been further reduced drastically alters the
volume–pressure relation of the LA. The “ventricularized” LA
contracts before the left ventricle, and with ventricular systole
there is regurgitation through the native annulus with posterior
motion of the prosthesis. The normal LA “v” wave occurs after
complete atrial relaxation as pulmonary venous blood fills the
LA against a closed mitral valve and depends on five factors: 1)
volume of blood entering the atrium (either from the pulmo-
nary veins or the left ventricle if there is MR) during ventric-
ular systole; 2) rate of forward flow into the atrium; 3)
compliance of the LA/pulmonary vein chamber; 4) systemic
afterload; and 5) left ventricular contractile force (6).
Most studies investigating LA hemodynamic data associ-
ated with abnormal mitral valves have been in adults with
acquired disease. In contrast, our study involves infants
with congenital MS. Tall LA “v” waves may occur in MR, but
with poor sensitivity and specificity (7–13). The highest “v”
waves are seen in acute MR when the LA is small and less
distensible, whereas in chronic MR with slow dilation over
time, the systolic atrial filling is better absorbed by a more
compliant LA with concomitantly lower “v” waves (8,14).
Indeed, very prominent “v” waves have been reported after
mitral valve replacement when there is extensive fibrosis and
scarring of the LA (“stiff left atrial syndrome”) (15). Thus we
suggest that after SMVR the “v” wave is contributed to by a
small, stiff LA, which quickly fills and is unable to fulfill its
requirement as an easily distensible reservoir for pulmonary
venous blood during ventricular systole (16) by upward move-
ment of the prosthesis in systole (13) and elevated LVED
pressure (9), these last two mechanisms being evident in
almost all of our patients.
Most investigators suggest that extraparenchymal pulmo-
nary venous flow is an inverted record of LA pressure changes
and minimal pulmonary vein flow coincides with the peak of
the LA “v” wave (17–22). However, in patients with SMVR
with the onset of diastole and high LA pressures, there will be
rapid pulmonary vein and LA emptying accounting for a rapid
decline in the early diastolic gradient.
Pulmonary hypertension. It is a source of concern that
there has been little reduction in the PA pressure. Indeed, the
only patient in whom this decreased to normal had acquired
rather than congenital left heart disease. This is in contrast to
improvement in pulmonary vascular pressures in adults with
acquired mitral valve disease (23–26). Children with ob-
structed total anomalous pulmonary venous connection and
hypoplastic left heart syndrome have increased muscularity
and intimal lesions of the pulmonary veins (27,28). Thus there
are some differences between pulmonary vascular changes due
to acquired and congenital left ventricular inflow obstruction.
The extraparenchymal pulmonary veins are highly compliant
structures that isolate the lung capillaries from LA pressure
events (20,29). Presumably the pulmonary veins in children
with congenital MS lose this capacity and this, coupled with the
continued elevation in LVED pressure, accounts for the
persistence of pulmonary hypertension. Interestingly, in two of
our patients the pulmonary vascular bed remains reactive to
vasodilator drugs (30).
Conclusions. Supraannular mitral valve replacement pro-
vides effective relief of MS or MR in children whose native
annulus is too small to accommodate a prosthesis. However,
their outlook remains poor because of associated left heart
obstruction and persistent LVED and PA hypertension. Left
atrial “v” wave to left ventricular diastolic gradients do not
indicate prosthetic valve obstruction, as “a” wave to left
ventricular end-diastolic gradients are uncommon. Similarly,
postoperative high LA “v” waves reflect the underlying LA
pathology rather than prosthetic valve incompetence.
We gratefully acknowledge Kimberlee Gauvreau, ScD, Harvard School of Public
Health, for her help and advice with the statistical analysis.
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